CitroTech Inc.
CITR- Exchange
- NYSE
- Industry
- Chemicals & Allied Products
- SEC CIK
- 0000894556
In the last 90 days, CitroTech Inc. insiders filed 1 open-market purchase and 0 sales; 26 institutions reported holding it in 13F filings for Q2 2026, worth $8.70M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 11, 2026, 1:11 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $36.8M (1546.9% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023! | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K/A | 10-K | 10-K |
| Reported | – | – | – | – | – |
| Revenue | $2.38M | $808.4K | $520.6K | $62.7K | – |
| Cost of revenue | $1.85M | $554.2K | $193.9K | $1.89K | $18.6K |
| Gross profit | – | – | $387.1K | $60.8K | $20.3K |
| Operating expenses | $18.9M | $6.11M | $10.6M | $2.98M | $58.2K |
| Research and development | $198.5K | $14.0K | – | – | – |
| Selling, general and administrative | $1.59M | $498.4K | $322.9K | $377.7K | $3.67K |
| Operating income | -$16.5M | -$5.30M | -$10.1M | -$2.92M | -$37.9K |
| Interest expense | $1.51M | – | $4.33K | $255 | $1.47K |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$36.8M | -$6.88M | -$10.1M | -$2.91M | -$95.0K |
| EPS, basic | $-2.96 | – | $-0.10 | $-0.05 | $0.00 |
| EPS, diluted | $-2.96 | $-0.14 | $0.00 | $-0.04 | – |
| Weighted shares, basic | 12.4M | 50.3M | 96.7M | 62.3M | 22.9M |
| Weighted shares, diluted | 12.4M | 50.3M | 96.7M | 75.3M | – |
| Margins and growth | |||||
| Gross margin | – | – | 74.4% | 97.0% | – |
| Operating margin | -692.7% | -656.2% | -1939.5% | -4652.4% | – |
| Net margin | -1546.9% | -851.3% | -1940.3% | -4635.3% | – |
| Revenue growth, year over year | +194.6% | +55.3% | +730.0% | – | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K/A | 10-K | 10-K |
| Reported | – | – | – | – | – |
| Cash and equivalents | $6.27M | $775.1K | $549.8K | – | $5.47K |
| Accounts receivable | $209.0K | $317.5K | $427.4K | – | – |
| Inventory | $620.8K | $324.7K | $230.2K | $114.6K | – |
| Total current assets | $7.42M | $1.62M | $1.22M | $170.1K | $5.47K |
| Property, plant and equipment | $630.3K | $111.4K | $7.30K | $4.55K | $291.4K |
| Intangible assets | $5.33M | $3.70M | $3.95M | $0 | – |
| Total assets | $14.2M | $5.48M | $5.30M | $4.41M | $330.2K |
| Short-term debt | – | $96.8K | – | – | – |
| Total current liabilities | $2.17M | $2.16M | $1.62M | $1.06M | $383.1K |
| Total liabilities | $2.92M | $2.16M | $1.67M | $1.06M | $383.1K |
| Shareholders' equity | $11.3M | $3.32M | $3.64M | $3.35M | -$52.9K |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K/A | 10-K | 10-K |
| Reported | – | – | – | – | – |
| Operating cash flow | -$5.87M | -$1.94M | -$1.21M | -$708.5K | -$24.2K |
| Capital expenditures | $194.0K | $0 | $4.01K | $5.35K | – |
| Free cash flow | -$6.06M | -$1.94M | -$1.22M | -$713.8K | – |
| Depreciation and amortization | $329.3K | $264.7K | $248.5K | $15.9K | – |
| Stock-based compensation | $19.1M | $1.86M | $8.97M | $2.10M | $0 |
| Investing cash flow | -$294.0K | $0 | -$4.01K | -$5.35K | -$287.1K |
| Financing cash flow | $11.7M | $2.16M | $1.71M | $763.8K | $316.8K |
| Net change in cash | – | – | $494.3K | $50.0K | $5.47K |
| Ratio | |||||
| Stock-based compensation, % of revenue | 803.7% | 230.3% | 1722.3% | 3347.6% | – |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 10, 2026 | 25.0M | +42.2% | SEC |
| Aug 7, 2026 | 22.6M | −66.1% | SEC |
| May 14, 2026 | 22.4M | −64.5% | SEC |
| Mar 30, 2026 | 19.2M | −63.4% | SEC |
| Nov 12, 2025 | 17.6M | −52.3% | SEC |
| Aug 12, 2025 | 66.6M | +82.1% | SEC |
| May 15, 2025 | 63.0M | +73.6% | SEC |
| Mar 21, 2025 | 52.4M | +44.3% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
- A column marked ! failed an accounting identity (gross profit = revenue − cost of revenue, or assets = liabilities + equity, within 1%). Its numbers are shown as filed.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.